Prospective Multicentre Non-Interventional Study to Assess the Patterns of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice

Trial Profile

Prospective Multicentre Non-Interventional Study to Assess the Patterns of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice

Recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Mar 2018

At a glance

  • Drugs Follitropin delta (Primary)
  • Indications Ovarian disorders
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms PROFILE
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 02 Mar 2018 Status changed from not yet recruiting to recruiting.
    • 12 Feb 2018 Planned initiation date changed from 31 Jan 2018 to 1 Mar 2018.
    • 11 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top